Third Harmonic Bio (THRD) Announces Phase 1 Clinical Results for THB335, Provides Corporate Strategic Update Feb 11, 2025 07:00AM
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update Feb 11, 2025 07:00AM
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September Sep 10, 2024 04:00PM
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference Feb 26, 2024 04:00PM
Cowen Starts Third Harmonic Bio (THRD) at Outperform Oct 10, 2022 05:36AM


Sep 19, 2022 04:10PM Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Sep 15, 2022 11:37AM Third Harmonic Bio (THRD) IPO Open 21% Higher
Sep 13, 2022 04:47PM 7 Things to Know About the Upcoming $650 Million IPO for Third Harmonic Bio, Inc. (THRD)